| |
| |
|
| Insider
Information: |
Smith Jeffrey T L |
| Relationship: |
Managing Director |
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alder Biopharmaceuticals Inc |
ALDR |
Managing Director |
2019-10-22 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
67 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALDR |
Alder Biopharmaceuticals ... |
Sr. VP Translational Medicine |
• – – |
2014-11-24 |
4 |
S |
$16.91 |
$153,735 |
D/D |
(9,090) |
0 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Managing Director |
• – – |
2019-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
9,288 |
10,119 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Managing Director |
• – – |
2018-05-16 |
4 |
AS |
$15.03 |
$182,758 |
D/D |
(12,161) |
831 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Managing Director |
• – – |
2018-05-16 |
4 |
OE |
$0.99 |
$16,739 |
D/D |
12,161 |
12,992 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Managing Director |
• – – |
2018-06-01 |
4 |
AS |
$17.81 |
$217,127 |
D/D |
(12,161) |
831 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Managing Director |
• – – |
2018-06-01 |
4 |
OE |
$0.99 |
$16,739 |
D/D |
12,161 |
12,992 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Managing Director |
• – – |
2018-07-02 |
4 |
AS |
$15.49 |
$188,364 |
D/D |
(12,161) |
831 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Managing Director |
• – – |
2018-07-02 |
4 |
OE |
$0.99 |
$16,739 |
D/D |
12,161 |
12,992 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Sr. VP Translational Medicine |
• – – |
2016-06-03 |
4 |
S |
$29.79 |
$485,933 |
D/D |
(16,090) |
0 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Sr. VP Translational Medicine |
• – – |
2016-06-03 |
4 |
OE |
$1.27 |
$20,354 |
D/D |
16,090 |
16,090 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Managing Director |
• – – |
2019-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
16,230 |
21,502 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Sr. VP Translational Medicine |
• – – |
2014-11-21 |
4 |
S |
$15.71 |
$314,118 |
D/D |
(20,000) |
9,090 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Managing Director |
• – – |
2019-10-22 |
4 |
D |
$18.00 |
$387,036 |
D/D |
(21,502) |
0 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Managing Director |
• – – |
2019-09-16 |
4 |
OE |
$3.47 |
$135,902 |
D/D |
32,728 |
38,000 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Managing Director |
• – – |
2019-09-16 |
4 |
AS |
$18.44 |
$603,504 |
D/D |
(32,728) |
5,272 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Sr. VP Translational Medicine |
• – – |
2015-05-21 |
4 |
OE |
$0.06 |
$3,004 |
D/D |
54,616 |
54,616 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Sr. VP Translational Medicine |
• – – |
2015-05-21 |
4 |
S |
$38.92 |
$2,125,496 |
D/D |
(54,616) |
0 |
0 |
- |
|
67 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
